| |
 |
Editorial [Hot Topic: Multidrug Resistance: Genes, Polymorphisms, Biologic Effects, Reversal and Treatment in Cancer Chemotherapy (Guest Editor: Jeanny B. Aragon-Ching)]
 |
| |
|
pp.582-582 (1) Author: Jeanny B. Aragon-Ching |
| |
|
|
| |
|
Pharmacogenetics of Drug Metabolizing Enzymes and Transporters: Effects on Pharmacokinetics and Pharmacodynamics of Anticancer Agents
|
| |
|
pp.583-592 (10) Author: Norman H. Lee |
| |
|
|
| |
|
Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors
|
| |
|
pp.593-600 (8) Authors: Jahan Tavakoli, Jeanny B. Aragon-Ching |
| |
|
|
| |
|
The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
|
| |
|
pp.601-616 (16) Authors: Lokesh Jain, Sophia Abraham, Stacy S. Shord |
| |
|
|
| |
|
Pharmacogenomics of Human ABC Transporter ABCC11 (MRP8): Potential Risk of Breast Cancer and Chemotherapy Failure
 |
| |
|
pp.617-624 (8) Authors: Yu Toyoda, Toshihisa Ishikawa |
| |
|
|
| |
|
ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
|
| |
|
pp.625-633 (9) Authors: Robert W. Robey, Paul R. Massey, Laleh Amiri-Kordestani, Susan E. Bates |
| |
|
|
| |
|
Pomegranate Extract, A Prooxidant with Antiproliferative and Proapoptotic Activities Preferentially Towards Carcinoma Cells
|
| |
|
pp.634-643 (10) Authors: Jeffrey H. Weisburg, Alyssa G. Schuck, Malki S. Silverman, Channa G. Ovits-Levy, Loriel J. Solodokin, Harriet L. Zuckerbraun, Harvey Babich |
| |
|
|
| |
|
Blockade of MUC1 Expression by Glycerol Guaiacolate Inhibits Proliferation of Human Breast Cancer Cells
|
| |
|
pp.644-650 (7) Authors: J. S. Smith, J. Colon, R. Madero-Visbal, B. Isley, S. D. Konduri, C. H. Baker |
| |
|
|
